KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareTrust REIT (CTRE) Shares Outstanding (Weighted Average) (2016 - 2025)

CareTrust REIT (CTRE) has 13 years of Shares Outstanding (Weighted Average) data on record, last reported at $203.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 31.56% year-over-year to $203.6 million; the TTM value through Dec 2025 reached $203.6 million, up 31.56%, while the annual FY2025 figure was $203.6 million, 31.56% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $203.6 million in Q4 2025 per CTRE's latest filing, down from $211.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $211.7 million in Q3 2025 and bottomed at $95.4 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $127.3 million, with a median of $99.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 0.23% in 2021, then soared 46.23% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $96.0 million in 2021, then rose by 0.71% to $96.7 million in 2022, then increased by 9.57% to $106.0 million in 2023, then surged by 46.09% to $154.8 million in 2024, then surged by 31.56% to $203.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $203.6 million in Q4 2025, $211.7 million in Q3 2025, and $189.8 million in Q2 2025.